53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease

描述（由申请人提供）： 第53届托马斯L. Petty白杨肺部会议的主题是“肺部疾病的系统生物学-'组学'时代的进展。“会议强调基础科学、转化科学和临床科学之间的整合，重点是利用新技术研究肺部疾病的发病机制、治疗方法和结果。由十二个“国家的最先进的”演讲锚定，专题会议将解决单基因和复杂的遗传疾病，基因组和蛋白质组学方法，表观基因组，综合信息学和个性化医疗。来自加州旧金山弗朗西斯科的医学博士Dean Sheppard将担任会议总结人。主要目标包括：1）为临床医生和研究人员提供一个国际论坛，以交流与肺的临床问题和研究有关的想法; 2）满足参与一个知识每五年翻一番的领域的公认需求; 3）为参与者提供一个机会，通过与国内和国际公认的临床医生和研究人员进行审查和讨论，专注于一个单一的主题;以及4）提供进一步研究肺部和危重病护理医学的动力。 公共卫生相关性： 第53届托马斯L.佩蒂白杨肺会议是“系统生物学的肺部疾病-进展的'组学'时代。“重点将是基础科学、转化科学和临床科学之间的整合;会议将重点关注利用新技术来研究肺部疾病的发病机制、治疗方法和结果。

DESCRIPTION (provided by applicant): The theme of the 53rd Annual Thomas L. Petty Aspen Lung Conference is "Systems Biology of Lung Diseases - Progress in the 'Omics' Era." With an emphasis on integration between basic, translational and clinical sciences, the meeting will focus on the utilization of newer technologies to investigate the pathogenesis, treatments, and outcomes of lung diseases. Anchored by twelve "state-of-the-art" presentations, thematic sessions will address single gene and complex genetic disorders, genomic and proteomic approaches, the epigenome, integrative informatics and personalized medicine. Dean Sheppard, MD, from the University of California San Francisco, will be the Conference Summarizer. The main objectives include 1) provide an international forum for clinicians and researchers to exchange ideas relating to clinical problems and research of the lung; 2) fill a recognized need for participation in a field where knowledge is doubling every five years; 3) provide an opportunity for participants to focus on a single topic exhaustively by review and discussion with nationally and internationally recognized clinicians and researchers; and 4) provide an impetus to further research in pulmonary and critical care medicine. PUBLIC HEALTH RELEVANCE: The theme of the 53rd Annual Thomas L. Petty Aspen Lung Conference is "Systems Biology of Lung Diseases - Progress in the 'Omics' Era." The emphasis will be on the integration between basic, translational and clinical sciences; the meeting will focus on the utilization of newer technologies to investigate the pathogenesis, treatments, and outcomes of lung diseases.